Clinical Trial Update: A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial to evaluate metformin's effect on endogenous neural progenitor cells in children and young adults with multiple sclerosis; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Multiple Sclerosis (MS) | Phase 1, Phase 2 | Status: RECRUITING